Terms: = Kidney tumors AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25
46 results:
1. Circular RNA CSPP1 motivates renal cell carcinoma carcinogenesis and the Warburg effect by targeting rac1 through microRNA-493-5p.
Zhang D; Yang X; Luo Q; Fu D; Li H; Zhang P; Tie C
Acta Biochim Pol; 2023 Sep; 70(3):693-701. PubMed ID: 37722005
[TBL] [Abstract] [Full Text] [Related]
2. Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.
Sonawane V; Ghosalkar J; Achrekar S; Joshi K
Sci Rep; 2023 Apr; 13(1):5659. PubMed ID: 37024613
[TBL] [Abstract] [Full Text] [Related]
3. SAMHD1-induced endosomal FAK signaling promotes human renal clear cell carcinoma metastasis by activating rac1-mediated lamellipodia protrusion.
An S; Vo TTL; Son T; Choi H; Kim J; Lee J; Kim BH; Choe M; Ha E; Surh YJ; Kim KW; Seo JH
Exp Mol Med; 2023 Apr; 55(4):779-793. PubMed ID: 37009792
[TBL] [Abstract] [Full Text] [Related]
4. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma.
Yang Y; Ye F; Xia T; Wang Q; Du J
BMC Cancer; 2022 Dec; 22(1):1355. PubMed ID: 36575439
[TBL] [Abstract] [Full Text] [Related]
5. FGD5 regulates endothelial cell PI3 kinase-β to promote neo-angiogenesis.
Azad AK; Farhan MA; Murray CR; Suzuki K; Eitzen G; Touret N; Moore RB; Murray AG
FASEB J; 2022 Jan; 36(1):e22080. PubMed ID: 34882832
[TBL] [Abstract] [Full Text] [Related]
6. HACE1 blocks HIF1α accumulation under hypoxia in a rac1 dependent manner.
Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
[TBL] [Abstract] [Full Text] [Related]
7. KANK family proteins in cancer.
Tadijan A; Samaržija I; Humphries JD; Humphries MJ; Ambriović-Ristov A
Int J Biochem Cell Biol; 2021 Feb; 131():105903. PubMed ID: 33309958
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R
Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766
[TBL] [Abstract] [Full Text] [Related]
9. DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traits.
Chi HC; Tsai CY; Wang CS; Yang HY; Lo CH; Wang WJ; Lee KF; Lai LY; Hong JH; Chang YF; Tsai MM; Yeh CT; Wu CH; Hsieh CC; Wang LH; Chen WJ; Lin KH
Oncogene; 2020 Sep; 39(37):5933-5949. PubMed ID: 32753649
[TBL] [Abstract] [Full Text] [Related]
10. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
[TBL] [Abstract] [Full Text] [Related]
11. Recent Advances in Pathology: the 2020 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Coates PJ
J Pathol; 2020 Apr; 250(5):475-479. PubMed ID: 32346919
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA NR2F2-AS1 Upregulates rac1 to Increase Cancer Stemness in Clear Cell Renal Cell Carcinoma.
Chen L; Zhang D; Ding T; Liu F; Xu X; Tian Y; Xiao J; Shen H
Cancer Biother Radiopharm; 2020 May; 35(4):301-306. PubMed ID: 32109138
[No Abstract] [Full Text] [Related]
13. Trk inhibitor GNF‑5837 suppresses the tumor growth, survival and migration of renal cell carcinoma.
Chen Y; Wang H; Chen Y; Wang M; Ding G; Li T
Oncol Rep; 2019 Nov; 42(5):2039-2048. PubMed ID: 31485624
[TBL] [Abstract] [Full Text] [Related]
14. Computational identification and analysis of early diagnostic biomarkers for kidney cancer.
Tang T; Du X; Zhang X; Niu W; Li C; Tan J
J Hum Genet; 2019 Oct; 64(10):1015-1022. PubMed ID: 31350524
[TBL] [Abstract] [Full Text] [Related]
15. In silico repurposing the rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma.
Hsieh YY; Liu TP; Yang PM
Pathol Res Pract; 2019 Jun; 215(6):152373. PubMed ID: 30871916
[TBL] [Abstract] [Full Text] [Related]
16. Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma.
Hagiwara N; Watanabe M; Iizuka-Ohashi M; Yokota I; Toriyama S; Sukeno M; Tomosugi M; Sowa Y; Hongo F; Mikami K; Soh J; Fujito A; Miyashita H; Morioka Y; Miki T; Ukimura O; Sakai T
Cancer Lett; 2018 Sep; 431():182-189. PubMed ID: 29778569
[TBL] [Abstract] [Full Text] [Related]
17. Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.
Joshi S; Singh AR; Durden DL
Cancer Chemother Pharmacol; 2015 Mar; 75(3):595-608. PubMed ID: 25578041
[TBL] [Abstract] [Full Text] [Related]
18. Activin B antagonizes RhoA signaling to stimulate mesenchymal morphology and invasiveness of clear cell renal cell carcinomas.
Wacker I; Behrens J
PLoS One; 2014; 9(10):e111276. PubMed ID: 25343250
[TBL] [Abstract] [Full Text] [Related]
19. Trans-homophilic interaction of CADM1 activates PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg.
Murakami S; Sakurai-Yageta M; Maruyama T; Murakami Y
PLoS One; 2014; 9(9):e110062. PubMed ID: 25268382
[TBL] [Abstract] [Full Text] [Related]
20. Trans-homophilic interaction of CADM1 activates PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg.
Murakami S; Sakurai-Yageta M; Maruyama T; Murakami Y
PLoS One; 2014; 9(2):e82894. PubMed ID: 24503895
[TBL] [Abstract] [Full Text] [Related]
[Next]
